Our strategic research provides essential insights into the key challenges and opportunities that are shaping the future of the pharma industry.
We are here to help you identify new opportunities. Through collaboration with independent experts, we analyze pricing and reimbursement issues and regulatory environments across major developed and emerging markets, in addition to assessing product launch and lifecycle management strategies.
Our strategy portfolio will help you to identify key issues and developments across the drug discovery and development process, from target selection and validation to drug safety testing, drug formulation, clinical trial design, and the expanding diagnostics sector. And of course, a key factor to consider throughout is the most appropriate outsourcing strategy.
I believe Datamonitor Healthcare provides a validated source of information covering a wide range of pharmaceutical issues & companies. I have recommended it to several colleagues.
Business Intelligence Director, TAKEDA
Our R&D research identifies and examines cutting-edge technologies and novel approaches shaping the future of novel drug discovery and delivery and their impact on the existing landscape. This coverage also includes commercially significant new in vitro diagnostics technologies, and changing regulations and requirements influencing clinical trial design.
Our case-study analysis into the application of various lifecycle management strategies will help you to understand how to maximize return on investment from branded pharmaceuticals. Our coverage provides analysis of the most effective approaches to brand management, including successful implementation of product positioning/repositioning and evaluations of generics growth and defense strategies.
Use our Market Access insights to understand healthcare systems and key pricing, reimbursement, and regulatory developments across the traditional seven major markets in addition to growth markets. Case-study insights will help you to identify best practice in the application of product launch strategies and review how to optimize salesforce effectiveness strategies.
Review the latest issues across the value chains of clinical research and contract manufacturing and assess the key strategies employed by leading players when developing partnerships with CROs or CMOs. Our analysis provides coverage of major providers in both fields, with insights into regulatory requirements for outsourced projects in new clinical trial locations and best practices to ensure efficient recruitment and cost control.